Global Virus Network’s Annual Meeting Fortifies Bonds on the African Continent to Catalyze Innovative Research, Strengthen Pandemic Preparedness, and Combat Scientific Misinformation
Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical stage RXR agonist for treatment of normal aging-related neurodegeneration, at the FASEB Science Research Conference on Cellular and Molecular Mechanisms of Brai Notified -
Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical stage RXR agonist for treatment of normal aging-related neurodegeneration, at the FASEB Science Research Conference on Cellular and Molecular Mechanisms of Brai
First cases using Smith+Nephew’s new CATALYSTEM™ Primary Hip System completed; surgeons hail precision, efficiency and reproducibility
Zoom and Mitel announce strategic partnership to deliver differentiated AI-first hybrid communications and collaboration solution for enterprises worldwide
AppTech Payments Provides Shareholder Update Highlighting Recent Strategic Partnership and Growth Milestones
Zymeworks to Present Preclinical Data on Antibody-Drug Conjugate Programs at EORTC-NCI-AACR Conference
International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on September 24th and 25th, 2024
